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Nanoparticles of zinc oxide (ZnO NPs) have been synthesised from naturally available Eggplant, Solanum melongena 
leaf extract. The methodology has been optimized to obtain ZnO NPs which as are characterized using UV-Visible, X-ray 
diffraction (XRD), Scanning Electron Microscope (SEM) and FT-Infra red (FTIR) tools to confirm their nano dimensions 
and chemical properties. The SPR band is obtained at 389 nm in UV-visible absorption spectrum confirmes the formation of 
ZnO NPs while the presence of OH, CO, CH2 and –COO groups at vibrational frequencies of 3500, 105, 3000 and 
1640 cm-1, respectively are observed from FTIR. Further, the SEM images show regular flakes like structure, and the 
average distribution of the nanoparticle is found to be around 100 nm. The newly synthesised ZnO NPs using leaf extract of 
Solanum melongena show considerable activity against both Gram-negative and Gram-positive bacteria. The ZnO NPs is 
proved to be more potent against Staphylococcus aureus than E. coli. 
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In the recent advancement of nanotechnology, the 
synthesis of metal nanoparticles (NPs) has evinced 
interest due to the growing need for fabrication of 
nano devices by green synthesis method. The 
classification of NPs based on their dimensions, 
morphology and chemical composition have shown 
encouraging properties such as antifungal and 
antibacterial activity. NPs or dendrimers and their 
nanocomposites have been explored for a variety of 
potential applications such as sensing devices, 
biosensors, storage devices and optical switching 
devices
1-6
. ZnO-NPs have a wide range of 
applications from electronic devices which are 
transparent to chemical and electrochemical sensors. 
ZnO NP is a widely used photocatalyst employed 
in breaking down big environmental pollutants and in 
the field of gas sensors it is applied as thin layers to 
obtain superior sensitivity and selectivity. ZnO is used 
in the food industry as an additive and in sunscreens 
to protect from UV radiation penetration into the 
skin
7-10
. The metal nanoparticles synthesised from 
plant extracts are found to be the ideal candidates for 
industrial synthesis and scale up. The advantage of 
nanoparticles prepared by green synthesis is that it 
provides control over the size and shape of the 
particles along with the highly stability of the 
solution. ZnO NPs can be produced using a variety of 
techniques from simple precipitation to thermal 
decomposition
1
. Currently, green methods are 
preferred due to the high cost of conventional 
materials and the pollution caused by these chemicals 
used in the synthesis, mainly solvent vapours from 
organic formulations that are toxic in nature. In green 
methods, the major disadvantage is that the reaction 
rates are slow and non uniformity in the collection of 
a batch of leaves and its consistency needs to be 
ensured
11-13
. The ZnO NPs have ideal semiconducting 
properties where the band gap range is about 3.36 eV 
making it an ideal candidate for electrical and 
electronic instrumental applications
14,15
. ZnO NPs 
process antimicrobial properties even with a few 
micro litres of the solution where the multiplication of 
pathogenic microbes is inhibited. This is well 
documented in literature, and it is effectively active 
against the Gram-negative and Gram-positive 
bacteria. Dobrucka & Dugaszewska (2015) have 
reported synthesis of ZnO NPs using Trifolium 
pratense flower extract and have evaluated its 






. Also, Santhoshkumar et al. 
(2017) have used Passiflora caerulea leaf extract to 





Anbuvannan (2017) has reported synthesis of ZnO 
nanoparticles using Solanum nigrum leaves
18
. On 
these lines, here, we explored production of ZnO NPs 
from Solanum melongena leaf extracts adopting green 
chemistry concepts. The prepared ZnO NPs have been 
characterized to study their absorption and vibrational 
properties, crystal and morphological structure with 
antifungal and antibacterial activity. 
 
Materials and Methods 
 
Materials 
Fresh leaf samples of Eggplant Solanum 
melongena were collected from the Salem District, 
Tamil Nadu, India. AR grade chemicals from Merck 
were used in these experiments.  
 
Preparation of the ZnO nanoparticles with leaf extract 
The leaves were washed with distilled water to 
clean the surfaces from dust particles and later air 
dried. 30 g of the dried leaves were transferred to a 
500 mL glass beaker and boiled with 300 mL of 
distilled water. This was carried out until the solution 
colour changes to light yellow. This solution was 
allowed to cool to 25C and then it was filtered. Now, 
to 60 mL of S. melongena leaf extract, 0.1 M of zinc 
nitrate was added followed by continuous stirring 
using a magnetic stirrer and the temperature was 
maintained at 60C. Heating was continued until the 
formation of yellow precipitation was converted as a 
paste and it further confirmed that the zinc nitrate was 
reduced. This was followed by sintering in air at  
400C for 4 h. This resulted in the formation of white 
coloured powder that was further mechanically 
ground to fine uniform powders. The schematic 
representation of synthesis of the ZnO NPs is shown 
in Scheme 1. The resulting powders were 




The synthesized ZnO NPs were assessed for their 
antimicrobial resistance with standard and clinical 
strain of Gram-positive and Gram-negative bacteria. 
The standard strains that were used in this study 
include Staphylococcus aureus, Escherichia coli, 
Pseudomonas aeruginosa clinical strains: S. aureus 
and P. aeruginosa) following the agar based 8 mm 
wells using diffusion method. This was followed by 
measuring the intensity of the solutions in the range 
0.8 to 1.0 at 600 nm wavelength for optical density 
measurements. This was followed by incubation of 
the plates at 35±1C for about 18 h. The antibacterial 
activity of ZnO NPs was calculated by measuring 
Minimum Inhibitory Concentration (MIC) and 
Minimum Bactericidal Concentration (MBC). Based 
on the spread of the micro-organisms the inhibition 
zone was calculated. 
 
Results and Discussion 
 
UV-visible studies 
The UV absorption spectra for the ZnO NPs were 
recorded using the wavelengths 200-900 nm. Fig. 1A 
confirms the presence of characteristic ZnO-NPs by 




Scheme 1 — Synthesis of ZnO NPs from Solanum melongena leaf extracts 
 




the peak at 290 nm relates to the freshly prepared leaf 
extract of S. melongena. The formation of ZnO-NPs 
can be further confirmed by the peak with intense 
absorption peak arising out of the electronic transition 
occurring in these nanoparticles
19
. The band gap 
energy was found to be 3.35 eV for the synthesised 
ZnO NPs due to increase in the size of the particles. 
These molecular spectroscopic properties enable the 
commercial use of ZnO NPs in various biomedical 
applications.  
 
Fourier Transform Infrared Spectroscopy (FTIR)  
The FTIR bands obtained for ZnO NPs synthesized 
by green route as given in Fig. 1B shows an intense 
broad peak at 3500 cm
-1
 due to alcoholic –OH stretch 
of residual organics. The alcoholic nature is 
confirmed by the –C-O stretch occurring at about 
1050 cm
-1
. The alkyl –CH2
-
 vibrations were weak and 
found below 3000 cm
-1
. The peak at about 1640 cm
-1 
belongs to C=O stretching group of acids. The wide 
peak at 3500 cm
-1
 includes the –OH stretching bands 





 bending modes. The –COO- 
vibration at about 1200 cm
-1 
is not clearly evident. 
The FTIR spectrum is shown in Fig. 1B. These results 
confirmed that during calcinations at 400ºC, the 
organics around the ZnO NPs were not completely 
expelled
20
. It’s evident that the synthesised material 
remains as visible yellow colour due to the 
sedimentation of the NPs.  
 
XRD analysis 
X-ray diffraction patterns shows (Fig. 2) the 
enhanced crystallinity effect with diffraction peaks 
associated with zinc oxide corresponding to (100), 
(002), (101), (102), (110), (103), (200), (112) and 
(201) and the peaks were indexed based on JCPDS 
file card No. 36-1451 and hexagonal (wurtzite) 
structure. This further confirms the formation of pure 
crystalline ZnO NPs.  
 
Scanning Electron Microscopy (SEM) 
The surface morphology of the synthesized ZnO 
NPs was analysed with SEM and is presented in Fig. 3. 




Fig. 1 — (A) Absorption spectrum and (B) FTIR spectrum of  





Fig. 2 — X-ray diffraction pattern of ZnO-NPs synthesised using 




Fig. 3 — Scanning electron micrograph showing the surface 
morphology of the ZnO-NPs 
 




stick-like structure with an average size of the particle 
ranging around 100 nm. The ZnO NPs have a uniform 




The antibacterial studies were carried out using 
Staphylococcus aureus Gram-negative bacterium,  
E. coli, Klebsiella pneumoniae and Pseudomonas 
aeruginosa Gram-negative bacteria, the process of 
sterilization of the disks and materials were carried 
out in an autoclave. Nutrient agar was medium used 
for carrying out the cultures S. aureus and E. coli at 
37C using an incubator. Optical density 
measurements were carried out to study the 
proliferation activity in the ranges 0.8 to 1.0 at  
600 nm. Minimum Inhibitory Concentration and 
Minimum Bactericidal Concentration were used to 
characterize the antibacterial properties. The bacteria 
were mopped uniformly on top of the plates using a 
sterile inoculation loop. After allowing the bacteria to 
dry (within 5-10 min) test solutions of ZnO of various 
concentrations (different particle sizes) were dropped 
within a disk of 8 mm diameter and zone of inhibition 
was measured after an incubation period of 18 h
21,22
. 
The following images are the zone of inhibition of E. 
coli (Fig. 4 A & B) and S. aureus (Fig. 4 C & D) 
bacterium whereas the K. pneumoniae and P. 
aeruginosa did not show any zone of inhibition since 
it has no resistance towards it. The linear increase in 
the zone of inhibition of E. coli and S. aureus as 
shown in the Fig. 5 A & B, respectively.  
 
Conclusions 
The ZnO nanoparticles were successfully 
synthesized using a green extract of Solanum 
melongena in an ecofriendly manner without the use 
of toxic chemicals and solvents. The various 
phytochemical constituents present in the extract act 
as reducing and capping agent on the formation of 
ZnO. The synthesized ZnO NPs were found to show 
electronic properties and typical vibration features 
from UV–visible and FTIR studies. The crystalline 
nature of the ZnO NPs was confirmed by XRD, and 
the morphological features, using SEM. The obtained 
ZnO NPs exhibited superior antibacterial activity 
against both Gram-negative and Gram-positive 
bacteria. The synthesized ZnO NPs using leaf extract 
of S. melongena proved to be more potent against 
Staphylococcus aureus than E. coli species. 
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Fig. 5 — Graphs for linear increase in the zone of inhibition for 
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